SlideShare a Scribd company logo
Aris G PHARMACOVIGILANCE & VIGI FLOW
AYANA R KUMAR
M Pharm, Pharmacology
DEPARTMENT OF PHARMACOLOGY 1
• Aris G is a leading pharmacovigilance and clinical
safety system.
• Enables companies to reduce safety risk for multiple
product types, including drugs, devices, vaccines and
combination products.
• Provides international safety reports for clinical and
post-marketing surveillance.
DEPARTMENT OF PHARMACOLOGY 2
• Improves the case processing life cycle and
reduces data entry time.
• Automates case processing and report
distribution with flexible workflows.
• Shortens the medical review and coding process.
• Integrates with document management systems,
Business Objects and clinical systems.
DEPARTMENT OF PHARMACOLOGY 3
• Aris G is a comprehensive adverse event management system.
• Aris G manages reports from all potential sources.
• Aris G supports an extensive feature set that facilitates the
Entry, Classification, Coding and Assessment of adverse
event reports.
DEPARTMENT OF PHARMACOLOGY 4
CASE HANDLING/ WORKFLOW
• Routed is based on company SOPs and policies.
• Manage the key activities such as Data entry, Assessment,
Coding and Reporting for full compliance
• Larger case processing teams - Aris G allows a workflow
manager to assign cases to individual team members and review
the activities of each individual.
DEPARTMENT OF PHARMACOLOGY 5
CASE QUERYING AND ANALYSIS
• Create complex queries
• Support of the published MedDRA, SMQs
• It performs
Case review
Run batch operations
Validations
Case updates
Reporting
Users to view or represent data in the form of charts or listings
for immediate analysis
DEPARTMENT OF PHARMACOLOGY 6
EXPEDITED AND AGGREGATE CASE REPORTING
• Aris G provides the report to,
FDA
MedWatch
CIOMS, PSUR,ASR and other major international reporting
forms.
• Electronic exchange - Aris G supports the export and import of
E2B files with recipient-based mapping for compliance with
local deviations.
DEPARTMENT OF PHARMACOLOGY 7
OPEN INTEGRATION
• Aris G is an open system based on industry standard architecture. It
can be easily integrated with third-party systems such as regulatory,
clinical, document management and medical information systems
to improve collaboration between departments and eliminate
transcription errors.
DEPARTMENT OF PHARMACOLOGY 8
A PROVEN SOLUTION FROM THE MARKET LEADER
• Most Complete, Mature and Proven drug safety software
solution on the market today.
• Aris Global has continually refined and updated Aris G in close
collaboration with its customers, including many of the world’s
largest life science organizations.
DEPARTMENT OF PHARMACOLOGY 9
Aris G key features include:
• Role-based data entry forms allow for fast and efficient
processing of received adverse event data.
• Automated workflows route cases through the data entry and
assessment process. Pre-configured workflows can be
configured for each product type.
DEPARTMENT OF PHARMACOLOGY 10
• A MedDRA - Browser
• Case assessment summary screen shows all key case
information, while allowing the assessor to add specific case
information.
• Extensive regulatory and management reporting capabilities,
including a suite of expedited and aggregate reports,
management reports.
DEPARTMENT OF PHARMACOLOGY 11
• Vigi Flow is an ICSR management system
• Developed and hosted by Uppsala Monitoring
Centre (UMC).
• It is compatible with the ICH-E2B standard for
electronic transmission of ICSRs.
DEPARTMENT OF PHARMACOLOGY 12
• Vigi flow includes
Data entry
 Assessment
 Storage
 Retrieval
 Communication with other parties
 It is web-based report management tool
 It is E2B compatible
DEPARTMENT OF PHARMACOLOGY 13
DEPARTMENT OF PHARMACOLOGY 14
SYSTEM REQUIREMENTS
• Internet via an encrypted (https) connection.
Mozilla Firefox or Internet Explorer
• It is recommended to have an Internet connection of at
least 1 Mb it/s, otherwise the system may be slow to
use.
DEPARTMENT OF PHARMACOLOGY 15
MAIN PARTS OF VIGI FLOW
• Create new reports
• Data entry and editing of reports
DEPARTMENT OF PHARMACOLOGY 16
• Communication between National and Regional centre
DEPARTMENT OF PHARMACOLOGY 17
• Commit reports
• Assessment page
Case narrative
Sender’s comments
Sender’s diagnosis
Imported sender’s comments and diagnosis
DEPARTMENT OF PHARMACOLOGY 18
Pros
• Combination of structured and free-text fields to encourage complete
data entry.
• Integrated dictionaries and terminologies ensures correct coding.
• Easy communication between national and regional centres.
• No need for local server upkeep and back-ups.
• Seamless transmission of reports to WHO/UMC.
DEPARTMENT OF PHARMACOLOGY 19
Cons
• Server (with national data) in another country might be against
national regulations
• Needs Internet access -at least 0.5 Mbit/s for a good experience
• Not 100% adaptable to local ideas of how it “should work
DEPARTMENT OF PHARMACOLOGY 20
REFERENCES
1.Pharmacovigilance Programme of India (PvPI). Indian
Pharmacopoeia commission. Page no : 27-35.
2. Aris G clinical safety and Pharmacovigilance. Page no:1-4.
3.Global provider of pharmacovigilance & regulatory services.
Forsight group of international. Page no : 2- 8.
DEPARTMENT OF PHARMACOLOGY 21
THANK YOU
DEPARTMENT OF PHARMACOLOGY 22

More Related Content

What's hot

List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
Shivanshu Bajaj
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
Shikha Choudhary
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
AnimatedWorld
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
Grandhi sandeep ganesh
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
E Poovarasan
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Shubhu20
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
SonaliJain736101
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCE
Sanju Kaladharan
 
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
AbhishekJoshi312
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology ppt
Shilpa thakur
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicals
Shivam Diwaker
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
Dinesh Gangoda
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
ARSHIKHANAM4
 
Target discovery and validation
Target discovery and validation Target discovery and validation
Target discovery and validation
ANAND SAGAR TIWARI
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
pharmacistnitish
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
Anurag Chourasia
 
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
Pooja Shimpi
 

What's hot (20)

List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptx
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
STATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCESTATISTICAL METHODS FOR PHARMACOVIGILANCE
STATISTICAL METHODS FOR PHARMACOVIGILANCE
 
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology ppt
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicals
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Target discovery and validation
Target discovery and validation Target discovery and validation
Target discovery and validation
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
 
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
Role of Free Radicals in Etiopathology of Neurodegenerative Disorders and Rec...
 

Similar to Aris G PHARMACOVIGILANCE AND VIGIFLOW

Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxTools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Dureshahwar khan
 
Diaspark Healthcare Technology Services
Diaspark Healthcare Technology ServicesDiaspark Healthcare Technology Services
Diaspark Healthcare Technology Services
Diaspark
 
Itc data-management-idms-sales-brochure
Itc data-management-idms-sales-brochureItc data-management-idms-sales-brochure
Itc data-management-idms-sales-brochure
JuanPablo Chavez
 
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
Ocean Software
 
Working with Argus Safety in a Global Community
Working with Argus Safety in a Global CommunityWorking with Argus Safety in a Global Community
Working with Argus Safety in a Global CommunityPerficient
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Holly Devine
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Managementbiinoida
 
Presentation SafetyDrugs
Presentation SafetyDrugsPresentation SafetyDrugs
Presentation SafetyDrugs
Andrea Garlanda
 
APT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALAPT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALTim Calvert
 
Types of pharmacovigilance softwares
Types of pharmacovigilance softwaresTypes of pharmacovigilance softwares
Types of pharmacovigilance softwares
Sollers College
 
Exploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGAExploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGA
TGA Australia
 
Is your company ready to meet today’s challenges?
Is your company ready to meet today’s challenges?Is your company ready to meet today’s challenges?
Is your company ready to meet today’s challenges?
Lidia Gasparotto
 
Electronic Document and Record Management (EDRMS)
Electronic Document and Record Management (EDRMS) Electronic Document and Record Management (EDRMS)
Electronic Document and Record Management (EDRMS)
6PM Solutions
 
Medical Devices - Servicing Medical Device Companies
Medical Devices - Servicing Medical Device CompaniesMedical Devices - Servicing Medical Device Companies
Medical Devices - Servicing Medical Device Companies
IBMElectronics
 
Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017
IntegraIT
 
Data Goverance Planning
Data Goverance PlanningData Goverance Planning
Data Goverance Planning
Ann McGee
 
GlobalLink NEXT 2017 EU - TransPort (Barcelona)
GlobalLink NEXT 2017 EU - TransPort (Barcelona)GlobalLink NEXT 2017 EU - TransPort (Barcelona)
GlobalLink NEXT 2017 EU - TransPort (Barcelona)
jwcampbe
 
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-RegulationsHow-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
Agaram Technologies
 
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Perficient, Inc.
 

Similar to Aris G PHARMACOVIGILANCE AND VIGIFLOW (20)

Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxTools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
 
Diaspark Healthcare Technology Services
Diaspark Healthcare Technology ServicesDiaspark Healthcare Technology Services
Diaspark Healthcare Technology Services
 
Itc data-management-idms-sales-brochure
Itc data-management-idms-sales-brochureItc data-management-idms-sales-brochure
Itc data-management-idms-sales-brochure
 
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
PILSrx, from Procurement to Patient, how the Australian Defence Force maximis...
 
Working with Argus Safety in a Global Community
Working with Argus Safety in a Global CommunityWorking with Argus Safety in a Global Community
Working with Argus Safety in a Global Community
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
Presentation SafetyDrugs
Presentation SafetyDrugsPresentation SafetyDrugs
Presentation SafetyDrugs
 
APT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINALAPT_Indigo FactSheet FINAL
APT_Indigo FactSheet FINAL
 
Types of pharmacovigilance softwares
Types of pharmacovigilance softwaresTypes of pharmacovigilance softwares
Types of pharmacovigilance softwares
 
Exploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGAExploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGA
 
Is your company ready to meet today’s challenges?
Is your company ready to meet today’s challenges?Is your company ready to meet today’s challenges?
Is your company ready to meet today’s challenges?
 
Electronic Document and Record Management (EDRMS)
Electronic Document and Record Management (EDRMS) Electronic Document and Record Management (EDRMS)
Electronic Document and Record Management (EDRMS)
 
Medical Devices - Servicing Medical Device Companies
Medical Devices - Servicing Medical Device CompaniesMedical Devices - Servicing Medical Device Companies
Medical Devices - Servicing Medical Device Companies
 
Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017
 
Data Goverance Planning
Data Goverance PlanningData Goverance Planning
Data Goverance Planning
 
brochur
brochurbrochur
brochur
 
GlobalLink NEXT 2017 EU - TransPort (Barcelona)
GlobalLink NEXT 2017 EU - TransPort (Barcelona)GlobalLink NEXT 2017 EU - TransPort (Barcelona)
GlobalLink NEXT 2017 EU - TransPort (Barcelona)
 
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-RegulationsHow-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
How-Logilab-ELN-helps-organizations-to-follow-GxP-Regulations
 
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
 

Recently uploaded

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 

Recently uploaded (20)

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 

Aris G PHARMACOVIGILANCE AND VIGIFLOW

  • 1. Aris G PHARMACOVIGILANCE & VIGI FLOW AYANA R KUMAR M Pharm, Pharmacology DEPARTMENT OF PHARMACOLOGY 1
  • 2. • Aris G is a leading pharmacovigilance and clinical safety system. • Enables companies to reduce safety risk for multiple product types, including drugs, devices, vaccines and combination products. • Provides international safety reports for clinical and post-marketing surveillance. DEPARTMENT OF PHARMACOLOGY 2
  • 3. • Improves the case processing life cycle and reduces data entry time. • Automates case processing and report distribution with flexible workflows. • Shortens the medical review and coding process. • Integrates with document management systems, Business Objects and clinical systems. DEPARTMENT OF PHARMACOLOGY 3
  • 4. • Aris G is a comprehensive adverse event management system. • Aris G manages reports from all potential sources. • Aris G supports an extensive feature set that facilitates the Entry, Classification, Coding and Assessment of adverse event reports. DEPARTMENT OF PHARMACOLOGY 4
  • 5. CASE HANDLING/ WORKFLOW • Routed is based on company SOPs and policies. • Manage the key activities such as Data entry, Assessment, Coding and Reporting for full compliance • Larger case processing teams - Aris G allows a workflow manager to assign cases to individual team members and review the activities of each individual. DEPARTMENT OF PHARMACOLOGY 5
  • 6. CASE QUERYING AND ANALYSIS • Create complex queries • Support of the published MedDRA, SMQs • It performs Case review Run batch operations Validations Case updates Reporting Users to view or represent data in the form of charts or listings for immediate analysis DEPARTMENT OF PHARMACOLOGY 6
  • 7. EXPEDITED AND AGGREGATE CASE REPORTING • Aris G provides the report to, FDA MedWatch CIOMS, PSUR,ASR and other major international reporting forms. • Electronic exchange - Aris G supports the export and import of E2B files with recipient-based mapping for compliance with local deviations. DEPARTMENT OF PHARMACOLOGY 7
  • 8. OPEN INTEGRATION • Aris G is an open system based on industry standard architecture. It can be easily integrated with third-party systems such as regulatory, clinical, document management and medical information systems to improve collaboration between departments and eliminate transcription errors. DEPARTMENT OF PHARMACOLOGY 8
  • 9. A PROVEN SOLUTION FROM THE MARKET LEADER • Most Complete, Mature and Proven drug safety software solution on the market today. • Aris Global has continually refined and updated Aris G in close collaboration with its customers, including many of the world’s largest life science organizations. DEPARTMENT OF PHARMACOLOGY 9
  • 10. Aris G key features include: • Role-based data entry forms allow for fast and efficient processing of received adverse event data. • Automated workflows route cases through the data entry and assessment process. Pre-configured workflows can be configured for each product type. DEPARTMENT OF PHARMACOLOGY 10
  • 11. • A MedDRA - Browser • Case assessment summary screen shows all key case information, while allowing the assessor to add specific case information. • Extensive regulatory and management reporting capabilities, including a suite of expedited and aggregate reports, management reports. DEPARTMENT OF PHARMACOLOGY 11
  • 12. • Vigi Flow is an ICSR management system • Developed and hosted by Uppsala Monitoring Centre (UMC). • It is compatible with the ICH-E2B standard for electronic transmission of ICSRs. DEPARTMENT OF PHARMACOLOGY 12
  • 13. • Vigi flow includes Data entry  Assessment  Storage  Retrieval  Communication with other parties  It is web-based report management tool  It is E2B compatible DEPARTMENT OF PHARMACOLOGY 13
  • 15. SYSTEM REQUIREMENTS • Internet via an encrypted (https) connection. Mozilla Firefox or Internet Explorer • It is recommended to have an Internet connection of at least 1 Mb it/s, otherwise the system may be slow to use. DEPARTMENT OF PHARMACOLOGY 15
  • 16. MAIN PARTS OF VIGI FLOW • Create new reports • Data entry and editing of reports DEPARTMENT OF PHARMACOLOGY 16
  • 17. • Communication between National and Regional centre DEPARTMENT OF PHARMACOLOGY 17
  • 18. • Commit reports • Assessment page Case narrative Sender’s comments Sender’s diagnosis Imported sender’s comments and diagnosis DEPARTMENT OF PHARMACOLOGY 18
  • 19. Pros • Combination of structured and free-text fields to encourage complete data entry. • Integrated dictionaries and terminologies ensures correct coding. • Easy communication between national and regional centres. • No need for local server upkeep and back-ups. • Seamless transmission of reports to WHO/UMC. DEPARTMENT OF PHARMACOLOGY 19
  • 20. Cons • Server (with national data) in another country might be against national regulations • Needs Internet access -at least 0.5 Mbit/s for a good experience • Not 100% adaptable to local ideas of how it “should work DEPARTMENT OF PHARMACOLOGY 20
  • 21. REFERENCES 1.Pharmacovigilance Programme of India (PvPI). Indian Pharmacopoeia commission. Page no : 27-35. 2. Aris G clinical safety and Pharmacovigilance. Page no:1-4. 3.Global provider of pharmacovigilance & regulatory services. Forsight group of international. Page no : 2- 8. DEPARTMENT OF PHARMACOLOGY 21
  • 22. THANK YOU DEPARTMENT OF PHARMACOLOGY 22